
Dwatro Laboratories sp. z o.o.
Manufacture of homogenised food preparations and dietetic food
Overview
Dwatro Laboratories offers dietary supplements made with Dwatro Lip liposomal technology, in oral gel sachets. Developed by pharmacist and scientist Dorota Wątróbska-Świetlikowska, the range includes supplements for immunity, joints, eyes, hair and sleep, without sugar, sweeteners, preservatives or fillers.
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $70,284 | |
| Profit allocation | Retained in reserve capital |
Filing timeliness
2 of 5 financial statements were filed late (the longest delay 84 days for 2021).
- 202508/07/2026
- 202428/06/2025
- 202328/06/2024
- 202217/07/2023
- 202107/10/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Dietary supplements
- Liposomal supplements
- Oral gels
- Drinkable collagen
- Vitamins
- Mineral components
Websites
The site is available in: Polish, English and Lithuanian.
- dwatrolaboratories.comLiposomalne suplementy diety w żelu – DWATRO LaboratoriesWooCommerceWordPress 3.7WebflowGoogle Tag ManagerYoast SEOWWPMLCloudflare
Authorized Representatives
Manner of representation
Each member of the management board is authorized to submit declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Ewa Wątróbska age 73 | 10 | $135.06 | 10% |
| 90 | $1,215.56 | 90% |
Dorota Anna Wątróbska-Świetlikowska and Ewa Wątróbska hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Sanctions and PEP
Sanctions
No matches (EU, UN, US, UK, MSWiA, World Bank)
PEP
No matches
Bank accounts
Registered as a VAT taxpayer on 2020-07-15.
40 1160 2202 0000 0004 6831 3950
50 1160 2202 0000 0004 6831 3964
55 1160 2202 0000 0004 6864 7942
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 13, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $48,616$48,616 | Polska Agencja Inwestycji I Handlu S.A. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Flavon Group Polska sp. z o.o. | $3,166,191.00 | flavonmax.com | ||
| Invex Remedies sp. z o.o. | $2,511,397.27 | invexremedies.pl | ||
| Nathealth sp. z o.o. | $1,713,528.70 | nathealth.pl | ||
| Pharma Nord sp. z o.o. | $1,701,654.59 | pharmanord.pl | ||
| Nutri Partner sp. z o.o. | $1,480,720.01 | nutri-partner.com | ||
| IOC sp. z o.o. | $878,940.46 | producentsuplementow.pl | ||
| Hepatica sp. z o.o. | $636,973.96 | hepatica.pl | ||
| Labify sp. z o.o. | $462,460.08 | labify.pl | ||
| Medso sp. z o.o. | $414,558.93 | medso.pl | ||
| Medcalm sp. z o.o. | $284,014.64 | medcalm.pl |
FAQ
Last updated: 2026-07-10